Follow
Universe
The universe contains all of space, time, matter, and energy. The observable universe measures approximately 93 billion light-years in diameter today, although the size of the entire universe remains unknown.
NOV 04, 2020 | 11:00 AM
DATE: November 4th, 2020 TIME: 11:00am PST As cell therapies become more complex, the need for robust analytical tools to characterize such products as they enter the clinic has increased in...
NOV 04, 2020 | 8:00 AM
Date: November 4, 2020 Time: 8:00am (PDT), 11:00am (EDT) High-content screening (HCS) is widely used for research in quantitative cellular biology and has proven to be a valuable tool in dru...
NOV 04, 2020 | 6:00 AM
Date: November 4, 2020 Time: 6:00am (PDT), 9:00am (EDT) The Global Scar Society was formed to gain consensus for and promote best practice in the prevention and treatment of abnormal & e...
NOV 03, 2020 | 8:00 AM
DATE: Novemb 3, 2020 TIME: 8:00am PST, 11:00am EST Following on from Miltenyi Biotec’s renowned webinar “Improve your CAR T cell research”, this webinar covers our latest p...
NOV 03, 2020 | 5:00 AM
DATE: November 3, 2020 TIME: 6:00am PDT Susceptibility profiles of anaerobes to antimicrobials have become unpredictable, thus reliable and user-friendly methods for routine susceptibility t...
NOV 02, 2020 | 8:00 AM
Date: November 2, 2020 Time: 8:00am PST. Rapid and accurate microbial diagnostic information can change treatment courses and outcomes for patients inflicted with infections. The limitation...
OCT 29, 2020 | 8:00 AM
Date: October 29, 2020 Time: 8:00am (PDT), 11:00am (EDT) What cell types cause and perpetuate disease? For many diseases, scientists only have guesses to this critical question. Single cell...
OCT 29, 2020 | 6:00 AM
Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
OCT 28, 2020 | 7:00 AM
Date: October 28, 2020 Time: 7:00am (PDT), 10:00am (EDT) Although chemotherapy remains the mainstay of systemic therapy, a large number of cancer patients fail to respond to it. About half o...
OCT 28, 2020 | 6:00 AM
DATE: October 28, 2020 TIME: 6:00am PST Tumorigenesis and cancer progression are affected by the tumor immune microenvironment (TIME). The TIME not only influences the efficiency of existing...
OCT 27, 2020 | 8:00 AM
DATE: October 27th, 2020 TIME: 8:00am PT Molecular diagnostic assay development and design is no simple task, and several factors affect the performance and usability of a test. Diagnostic c...
OCT 26, 2020 | 11:00 AM
This session introduces basic concepts of imaging-based high-throughput screening (HTS) and high-throughput profiling assay development. Imaging-based HTS assays are designed to evaluate a d...
OCT 22, 2020 | 1:35 PM
Precision oncology continues to evolve as additional clinically relevant biomarkers are identified. The challenges facing the clinical researchers include not only the ability to add additio...
OCT 22, 2020 | 1:35 PM
Precision oncology continues to evolve as additional clinically relevant biomarkers are identified. The challenges facing both diagnostic laboratories and clinicians include not only the abi...
OCT 22, 2020 | 1:15 PM
To identify genetic variants in archival human samples, researchers need a powerful NGS platform that can accommodate input DNA and RNA that is often low quality and/or low quantity. This ch...
OCT 22, 2020 | 12:25 PM
Myeloid neoplasms represent a highly heterogeneous group of diseases that encompass myeloproliferative, myelodysplastic (myeloproliferative/myelodysplastic) processes and acute myeloid leuke...
OCT 22, 2020 | 12:25 PM
Myeloid neoplasms represent a highly heterogeneous group of diseases that encompass myeloproliferative, myelodysplastic (myeloproliferative/myelodysplastic) processes and acute myeloid leuke...
OCT 22, 2020 | 12:05 PM
Molecular testing of NCSLC biopsies is extremely important in the care and management of these patients. However, NCSLC biopsies are typically very small and require multiple types of analys...
